Glenmark Secures USFDA Nod for Progesterone Vaginal Inserts, Targets USD 59 Million US Market Parthika Patel10 April 2026 9:22 PM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Progesterone...
Lupin Gets USFDA Approval for Xigduo XR Generic Dapagliflozin-Metformin Tablets Parthika Patel10 April 2026 9:14 PM ISTNew Delhi: Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and Metformin...
Domestic Pharma Growth Strong, US Market Drag to Weigh on Q4FY26 Earnings: Report sheeba farhat10 April 2026 9:01 PM ISTNew Delhi: India's pharmaceutical sector is likely to witness steady domestic growth but continued pressure in the US market in the fourth quarter of...
Aurobindo Pharma Secures USFDA Nod for Dapagliflozin-Metformin XR, Gains 180-Day Exclusivity Parthika Patel8 April 2026 9:22 PM ISTNew Delhi: Aurobindo Pharma Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and...
USFDA Approves Alembic's Dapagliflozin Tablets, Grants 180-Day Exclusivity Parthika Patel8 April 2026 8:47 PM ISTNew Delhi: Alembic Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration (USFDA) for its...
Alembic Pharma Gets USFDA Nod for Paroxetine ER Tablets Parthika Patel28 March 2026 8:27 PM ISTNew Delhi: Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its Paroxetine...
Natco Pharma Enters USD 3.2 Billion US Pomalidomide Market, Claims 180-Day Exclusivity sheeba farhat5 March 2026 9:43 PM ISTHyderabad: NATCO Pharma Limited, in partnership with Breckenridge Pharmaceutical, Inc., has announced the launch of Pomalidomide Capsules in the...
Aurobindo Pharma Q3 Net Profit Rises 8% to Rs 910 Cr sheeba farhat10 Feb 2026 4:00 PM ISTNew Delhi: Aurobindo Pharma on Monday said its consolidated net profit increased 8 per cent year-on-year to Rs 910 crore for the December quarter, led...
Rick Suarez Named Head of AstraZeneca's US Biopharma Business Amid USD 50 Billion Expansion Plan sheeba farhat12 Jan 2026 7:16 PM ISTBengaluru: AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the drugmaker's USD...
Gland Pharma Gets USFDA Approval for Olopatadine Ophthalmic Solution Farhat Nasim8 Jan 2026 6:08 PM ISTOlopatadine Hydrochloride Ophthalmic Solution is indicated for the treatment of ocular itching associated with allergic conjunctivitis, a common...
USFDA Grants Tentative Approval, 180-Day Exclusivity to Granules' Generic Amphetamine XR Farhat Nasim8 Jan 2026 3:11 PM ISTHyderabad: Granules Pharmaceuticals, Inc., a wholly owned subsidiary of Granules India Limited, has received tentative approval (TA) from the U.S....
Cipla Partner Pharmathen Receives 9 USFDA Observations Farhat Nasim7 Jan 2026 8:22 PM ISTCipla had earlier received final USFDA approval in May 2024 to market its generic Lanreotide injection in multiple strengths.
